DVA News and Press, DaVita Inc. From 05/02/23

DaVita Inc. to Participate in the BofA Securities Healthcare Conference 2023 PR Newswire DENVER , May 2, 2023 /PRNewswire/ -- DaVita Inc. (NYSE: DVA) today announced that its chief financial officer, Joel Ackerman, will participate in a fireside chat with in...

DaVita Inc. Schedules 1st Quarter 2023 Investor Conference Call PR Newswire DENVER , April 18, 2023 /PRNewswire/ -- DaVita Inc. (NYSE: DVA), announced today that it will hold its quarterly conference call to discuss first quarter results on Monday, May 8, 2023 ...

2023-04-14 11:28:52 ET Summary Pharmaceuticals/biotechnology is the only subsector with good value and quality scores. Healthcare equipment is the most overvalued one. IXJ: A global alternative to XLV. 10 stocks cheaper than their peers in April. This monthly art...

2023-04-14 05:48:00 ET Most institutional investors try not to purchase more than a 10% stake in a company because it comes with additional regulatory reporting requirements that can be burdensome. But that hasn't stopped Warren Buffett's company Berkshire Hathaway (NYSE: BRK.A) (...

2023-04-10 08:01:40 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips As the population of our country continues to age, treatments and disease detection will continue to increase in demand. Additionally, improvements in imaging, robotics, and AI technology conti...

Medtronic, DaVita launch Mozarc Medical, aimed at introducing new solutions for patients with kidney failure Canada NewsWire New, independent kidney health technology company will combine expertise from two industry leaders to drive care transformation DUBLIN and DEN...

2023-03-16 06:31:14 ET Summary The pharma/biotech subsector is undervalued by 16% relative to 11-year averages. Healthcare equipment is the less attractive subsector regarding both valuation and quality. Fast facts on PBE, a biotechnology and genomics ETF. 10 stocks cheape...

DaVita Inc. to Participate in the Barclays 2023 Global Healthcare Conference PR Newswire DENVER , March 13, 2023 /PRNewswire/ -- DaVita Inc. (NYSE: DVA) today announced that its chief financial officer, Joel Ackerman, will participate in a fireside chat with...

2023-03-08 16:23:51 ET Summary In a recent article I suggested international stocks as an alternative while the cap-weighted S&P 500 completed a downward rerating of high-priced growth stocks. The Vanguard FTSE Europe ETF with little tech or overpriced growth might serve as a ...

Summary Mixed Q4 results throughout the P&L and per-patient measures. Projects flat bottom-line growth in FY23, with further downsides in FCF. Valuations aren't supportive of a re-rating or valuation upside. Net-net, rate hold. Investor Summary DaVita Inc. ( ...